These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cerebrospinal fluid concentrations of functionally important amino acids and metabolic compounds in patients with mild cognitive impairment and Alzheimer's disease. Kaiser E; Schoenknecht P; Kassner S; Hildebrandt W; Kinscherf R; Schroeder J Neurodegener Dis; 2010; 7(4):251-9. PubMed ID: 20551690 [TBL] [Abstract][Full Text] [Related]
7. Amino acids and transaminases activity in ventricular CSF and in brain of normal and Alzheimer patients. D'Aniello A; Fisher G; Migliaccio N; Cammisa G; D'Aniello E; Spinelli P Neurosci Lett; 2005 Nov; 388(1):49-53. PubMed ID: 16039064 [TBL] [Abstract][Full Text] [Related]
8. Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer's disease and vascular dementia. Martinez M; Frank A; Diez-Tejedor E; Hernanz A J Neural Transm Park Dis Dement Sect; 1993; 6(1):1-9. PubMed ID: 8216758 [TBL] [Abstract][Full Text] [Related]
9. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Hansson O; Zetterberg H; Buchhave P; Londos E; Blennow K; Minthon L Lancet Neurol; 2006 Mar; 5(3):228-34. PubMed ID: 16488378 [TBL] [Abstract][Full Text] [Related]
10. CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects. Sunderland T; Rubinow DR; Tariot PN; Cohen RM; Newhouse PA; Mellow AM; Mueller EA; Murphy DL Am J Psychiatry; 1987 Oct; 144(10):1313-6. PubMed ID: 2889377 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126 [TBL] [Abstract][Full Text] [Related]
12. Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease. Jiménez-Jiménez FJ; Molina JA; Gómez P; Vargas C; de Bustos F; Benito-León J; Tallón-Barranco A; Ortí-Pareja M; Gasalla T; Arenas J J Neural Transm (Vienna); 1998; 105(2-3):269-77. PubMed ID: 9660105 [TBL] [Abstract][Full Text] [Related]
13. Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques. Peters JM; Hummel T; Kratzsch T; Lötsch J; Skarke C; Frölich L Am J Psychiatry; 2003 Nov; 160(11):1995-2002. PubMed ID: 14594747 [TBL] [Abstract][Full Text] [Related]
14. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease. Zubenko GS; Zubenko WN; McPherson S; Spoor E; Marin DB; Farlow MR; Smith GE; Geda YE; Cummings JL; Petersen RC; Sunderland T Am J Psychiatry; 2003 May; 160(5):857-66. PubMed ID: 12727688 [TBL] [Abstract][Full Text] [Related]
15. Glutamate uptake is decreased in platelets from Alzheimer's disease patients. Ferrarese C; Begni B; Canevari C; Zoia C; Piolti R; Frigo M; Appollonio I; Frattola L Ann Neurol; 2000 May; 47(5):641-3. PubMed ID: 10805335 [TBL] [Abstract][Full Text] [Related]
16. Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer's disease and healthy control subjects. Basun H; Forssell LG; Almkvist O; Cowburn RF; Eklöf R; Winblad B; Wetterberg L J Neural Transm Park Dis Dement Sect; 1990; 2(4):295-304. PubMed ID: 2078309 [TBL] [Abstract][Full Text] [Related]
17. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. Friedman JI; Harvey PD; Coleman T; Moriarty PJ; Bowie C; Parrella M; White L; Adler D; Davis KL Am J Psychiatry; 2001 Sep; 158(9):1441-8. PubMed ID: 11532729 [TBL] [Abstract][Full Text] [Related]
18. Excitatory amino acids in the cerebrospinal fluid of asphyxiated infants: relationship to hypoxic-ischemic encephalopathy. Hagberg H; Thornberg E; Blennow M; Kjellmer I; Lagercrantz H; Thiringer K; Hamberger A; Sandberg M Acta Paediatr; 1993 Nov; 82(11):925-9. PubMed ID: 7906573 [TBL] [Abstract][Full Text] [Related]
19. Graphomotor perseveration and wandering in Alzheimer's disease. Ryan JP; McGowan J; McCaffrey N; Ryan GT; Zandi T; Brannigan GG J Geriatr Psychiatry Neurol; 1995 Oct; 8(4):209-12. PubMed ID: 8561833 [TBL] [Abstract][Full Text] [Related]